|1.||Kaplan, Michael: 12 articles (11/2015 - 04/2002)|
|2.||Kaplan, M: 10 articles (10/2015 - 01/2000)|
|3.||Hammerman, Cathy: 9 articles (07/2015 - 04/2002)|
|4.||Hammerman, C: 7 articles (10/2015 - 03/2000)|
|5.||Baird, J Kevin: 7 articles (06/2015 - 03/2003)|
|6.||Gupte, Sachin A: 7 articles (02/2015 - 08/2005)|
|7.||Chiu, Daniel Tsun-Yee: 7 articles (01/2015 - 11/2002)|
|8.||White, Nicholas J: 7 articles (02/2014 - 04/2010)|
|9.||Huang, Ching-Shan: 7 articles (01/2008 - 07/2002)|
|10.||Bancone, Germana: 6 articles (04/2015 - 01/2008)|
|1.||Glucosephosphate Dehydrogenase Deficiency
06/01/2012 - "In this study we aimed to determine the prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in a Lebanese population and the clinical outcomes and associated adverse events encountered amongst affected patients. "
02/01/2011 - "The purpose of this study was to analyze a targeted screening program for glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PDdef) and clinical outcomes of G6PD-deficient vs G6PD normal newborns. "
08/01/2010 - "This study determined the epidemiological, clinical and laboratory profile of glucose-6-phosphate dehydrogenase (G6PD) deficiency in Baghdad (central Iraq) and compared it with previous data from Mosul (northern Iraq). "
01/01/2009 - "This study aimed to compare the detection rates of glucose-6-phosphate dehydrogenase (G6PD) deficiency in neonates by fluorescent spot test (FST), enzyme assay and molecular methods, and to identify which method was a significant predictor of severe hyperbilirubinaemia. "
05/01/2007 - "The purpose of this study was to evaluate the aetiology of indirect hyperbilirubinaemia and the prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in newborns who were admitted to Vali-e-Asr Hospital in Zanjan City during the period 2001-2003. "
10/01/2015 - "Deficiencies in human glucose-6-phosphate dehydrogenase, the initial enzyme in the pentose phosphate pathway (PPP), lead to a disturbed redox equilibrium in infected erythrocytes and partial protection against severe malaria. "
01/01/1991 - "This study was conducted on 823 male and female subjects to determine the frequency of glucose-6-phosphate dehydrogenase (G-6-PD) deficiency and sickle cell gene in Al-Qunfuda, a densely populated and malaria endemic region in western Saudi Arabia. "
06/22/1971 - "An electron cytochemical study of glucose-6-phosphate dehydrogenase activity in erythrocytes of malaria-infected mice, monkeys and chickens."
01/01/1971 - "An electron cytochemical study of glucose-6-phosphate dehydrogenase activity in malaria-infected erythrocytes."
05/20/2015 - "Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum were shown to protect G6PD-deficient populations from severe malaria. "
|3.||Sickle Cell Trait
01/01/2010 - "Blood donation from glucose-6-phosphate dehydrogenase (G6PD)-deficient and sickle cell trait (SCT) donors might alter the quality of the donated blood during processing, storage or in the recipient's circulatory system. "
05/03/1979 - "The overall frequency of sickle-cell trait was 7.8 per cent and of glucose-6-phosphate dehydrogenase dificiency 11.2 per cent. "
06/01/1968 - "Deficiency of erythrocyte glucose-6-phosphate dehydrogenase and sickle cell trait: a survey of Mahar students at Aurangabad, Maharashtra."
01/01/2012 - "Sickle cell trait, glucose-6-phosphate dehydrogenase (G6PD) deficiency, and α(+)-thalassaemia were observed in 2.8%, 9.6%, and 15.1%, respectively. "
03/01/2009 - "Genes for thalassaemia, haemoglobin S, Glucose-6-phosphate dehydrogenase which confer resistance to malaria are found in high frequencies in Nigeria, 25% of the population being carriers of the sickle cell trait while another 25% are hemizygous for the G6PD gene. "
01/01/1971 - "Glucose-6-phosphate dehydrogenase polymorphism: a valuable tool to study tumor origin."
12/01/1963 - "HISTOCHEMICAL STUDY ON THE LOCALIZATION OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE IN HUMAN TUMORS."
10/01/2015 - "Glucose-6-phosphate dehydrogenase (G6PD) is reported to elevate in various tumor cells. "
10/01/2015 - "Elevated glucose-6-phosphate dehydrogenase expression in the cervical cancer cases is associated with the cancerigenic event of high-risk human papillomaviruses."
01/01/2013 - "Glucose-6-phosphate dehydrogenase (G6PD), elevated in tumor cells, catalyzes the first reaction in the pentose-phosphate pathway. "
09/01/2008 - "Using glucose-6-phosphate dehydrogenase (G6PD)-deficient fibroblasts as a model, this study demonstrated that the cellular redox status affects infectivity as well as the outcome of enterovirus 71 (EV71) infection. "
01/01/2015 - "Glucose-6-phosphate dehydrogenase (G6PD)-deficient cells are highly susceptible to viral infection. "
01/01/2013 - "Glucose-6-phosphate dehydrogenase (G6PD)-deficient epithelial cells are less tolerant to infection by Staphylococcus aureus."
03/15/2008 - "Viral gene expression and viral particle production of glucose-6-phosphate dehydrogenase (G6PD)-deficient and G6PD-knockdown cells were much higher than their counterparts when human coronavirus (HCoV) 229E was applied at 0.1 multiplicity of infection. "
08/01/2006 - "Although mutations in the glucose-6-phosphate dehydrogenase (G6PD) gene result in several blood-related diseases in humans, they also confer resistance to malarial infection. "
|5.||glucose-6-phosphate dehydrogenase A-
|1.||Phototherapy (Light Therapy)
|3.||Neonatal Intensive Care
|4.||Renal Dialysis (Hemodialysis)